Patients accept therapy using embryonic stem cells for Parkinson’s disease: a discrete choice experiment

BACKGROUND: New disease-modifying ways to treat Parkinson’s disease (PD) may soon become a reality with intracerebral transplantation of cell products produced from human embryonic stem cells (hESCs). The aim of this study was to assess what factors influence preferences of patients with PD regardin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bywall, Karin Schölin, Drevin, Jennifer, Groothuis-Oudshoorn, Catharina, Veldwijk, Jorien, Nyholm, Dag, Widner, Hakan, van Vliet, Trinette, Jiltsova, Elena, Hansson, Mats, Johansson, Jennifer Viberg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571417/
https://www.ncbi.nlm.nih.gov/pubmed/37828462
http://dx.doi.org/10.1186/s12910-023-00966-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571417/
https://www.ncbi.nlm.nih.gov/pubmed/37828462
http://dx.doi.org/10.1186/s12910-023-00966-1

Ejemplares similares